Thomas Kammertoens

2.3k total citations
39 papers, 1.6k citations indexed

About

Thomas Kammertoens is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Thomas Kammertoens has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Thomas Kammertoens's work include Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (12 papers). Thomas Kammertoens is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (12 papers). Thomas Kammertoens collaborates with scholars based in Germany, United States and China. Thomas Kammertoens's co-authors include Thomas Blankenstein, Wolfgang Uckert, Zhihai Qin, Gerd Kempermann, Susanne A. Wolf, Barbara Steiner, Thomas Schüler, Christina Nassenstein, Simone Fulda and Klaus‐Michael Debatin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Thomas Kammertoens

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Kammertoens Germany	23	777	609	474	231	231	39	1.6k
Joseph R. Podojil United States	28	1.2k 1.6×	420 0.7×	606 1.3×	333 1.4×	205 0.9×	55	2.4k
Мikhail Pashenkov Russia	26	977 1.3×	316 0.5×	391 0.8×	250 1.1×	59 0.3×	70	1.8k
Emilia Maria Cristina Mazza Italy	19	938 1.2×	489 0.8×	531 1.1×	94 0.4×	123 0.5×	27	1.7k
Kevin D. Pavelko United States	23	770 1.0×	434 0.7×	437 0.9×	263 1.1×	136 0.6×	71	2.0k
Violeta Chiţu United States	22	1.5k 1.9×	421 0.7×	900 1.9×	777 3.4×	71 0.3×	38	2.9k
Corinne Ploix Switzerland	11	526 0.7×	144 0.2×	261 0.6×	286 1.2×	211 0.9×	17	1.2k
Álvaro Lladser Chile	25	1.2k 1.5×	811 1.3×	647 1.4×	115 0.5×	113 0.5×	46	2.1k
Mitsuhiro Kanamori Japan	12	603 0.8×	249 0.4×	290 0.6×	257 1.1×	75 0.3×	15	1.2k
Frédéric Brau France	20	759 1.0×	257 0.4×	678 1.4×	133 0.6×	133 0.6×	40	2.1k
Marta Ruiz Spain	22	715 0.9×	519 0.9×	589 1.2×	152 0.7×	113 0.5×	52	1.6k

Countries citing papers authored by Thomas Kammertoens

Since Specialization

Citations

This map shows the geographic impact of Thomas Kammertoens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kammertoens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kammertoens more than expected).

Fields of papers citing papers by Thomas Kammertoens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kammertoens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kammertoens. The network helps show where Thomas Kammertoens may publish in the future.

Co-authorship network of co-authors of Thomas Kammertoens

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kammertoens. A scholar is included among the top collaborators of Thomas Kammertoens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kammertoens. Thomas Kammertoens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gout, Evelyne, Sandra Ammann, Ralf Kühn, et al.. (2023). IFNγ binding to extracellular matrix prevents fatal systemic toxicity. Nature Immunology. 24(3). 414–422. 18 indexed citations

Klopfleisch, Robert, et al.. (2020). Stress hormones or general well-being are not altered in immune-deficient mice lacking either T- and B- lymphocytes or Interferon gamma signaling if kept under specific pathogen free housing conditions. PLoS ONE. 15(9). e0239231–e0239231. 1 indexed citations

Rathjen, Fritz G., et al.. (2020). Early-Life Stress Regulates Cardiac Development through an IL-4-Glucocorticoid Signaling Balance. Cell Reports. 33(7). 108404–108404. 17 indexed citations

Schreiber, Karin, Theodore Karrison, Kazuma Kiyotani, et al.. (2019). Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunology Research. 8(2). 192–202. 18 indexed citations

Knop, Laura, Katrin Deiser, Ulrich Kalinke, et al.. (2019). Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4+ T Cells in Chronic Lymphopenic Mice. Frontiers in Immunology. 10. 140–140. 6 indexed citations

Hamad, Ibrahim, Máté Kiss, Kirsten Bruderek, et al.. (2019). High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity. Frontiers in Immunology. 10. 1141–1141. 40 indexed citations

Leisegang, Matthias, Thomas Kammertoens, Wolfgang Uckert, & Thomas Blankenstein. (2016). Targeting human melanoma neoantigens by T cell receptor gene therapy. Journal of Clinical Investigation. 126(3). 854–858. 51 indexed citations

Zhang, Jinhua, Lin Chen, Xiaoman Liu, et al.. (2013). Fibroblast-Specific Protein 1/S100A4–Positive Cells Prevent Carcinoma through Collagen Production and Encapsulation of Carcinogens. Cancer Research. 73(9). 2770–2781. 68 indexed citations

Rothe, Michael, David Quarcoo, Svetlana Bozrova, et al.. (2013). IL‐13 but not IL‐4 signaling via IL‐4Rα protects mice from papilloma formation during DMBA/TPA two‐step skin carcinogenesis. Cancer Medicine. 2(6). 815–825. 8 indexed citations

10.

Briesemeister, Dana, Christian Friese, Elisabeth Dietz, et al.. (2012). Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates. Cytokine. 60(3). 626–633. 7 indexed citations

11.

Herrmann, Andreas, Christoph Loddenkemper, Thomas Kammertoens, et al.. (2011). Oncogene-Targeting T Cells Reject Large Tumors while Oncogene Inactivation Selects Escape Variants in Mouse Models of Cancer. Cancer Cell. 20(6). 755–767. 34 indexed citations

12.

Kammertoens, Thomas, Zhihai Qin, Dana Briesemeister, Albert Bendelac, & Thomas Blankenstein. (2011). B‐cells and IL‐4 promote methylcholanthrene‐induced carcinogenesis but there is no evidence for a role of T/NKT‐cells and their effector molecules (Fas‐ligand, TNF‐α, perforin). International Journal of Cancer. 131(7). 1499–1508. 23 indexed citations

13.

Shalapour, Shabnam, Cornelia Eckert, Karl Seeger, et al.. (2010). Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. Journal of Molecular Medicine. 88(3). 249–265. 35 indexed citations

14.

Wolf, Susanne A., Barbara Steiner, Akgül Akpınarlı, et al.. (2009). CD4-Positive T Lymphocytes Provide a Neuroimmunological Link in the Control of Adult Hippocampal Neurogenesis. The Journal of Immunology. 182(7). 3979–3984. 248 indexed citations

15.

Kammertoens, Thomas & Thomas Blankenstein. (2009). Making and circumventing tolerance to cancer. European Journal of Immunology. 39(9). 2345–2353. 13 indexed citations

16.

Nassenstein, Christina, Thomas Kammertoens, Tibor Z. Veres, et al.. (2007). Neuroimmune crosstalk in asthma: Dual role of the neurotrophin receptor p75NTR. Journal of Allergy and Clinical Immunology. 120(5). 1089–1096. 19 indexed citations

17.

Kammertoens, Thomas, Andreas Hutloff, David Quarcoo, et al.. (2006). The translocation motif of hepatitis B virus improves protein vaccination. Cellular and Molecular Life Sciences. 63(5). 627–635. 25 indexed citations

18.

Preiß, Susanne, Thomas Kammertoens, C. Lampert, Gerald Willimsky, & Thomas Blankenstein. (2005). Tumor‐induced antibodies resemble the response to tissue damage. International Journal of Cancer. 115(3). 456–462. 24 indexed citations

19.

Kammertoens, Thomas, Thomas Schüler, & Thomas Blankenstein. (2005). Immunotherapy: target the stroma to hit the tumor. Trends in Molecular Medicine. 11(5). 225–231. 74 indexed citations

20.

Kammertoens, Thomas, Wolfgang Gelbmann, Peter Karle, et al.. (2000). Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine. Cancer Gene Therapy. 7(4). 629–636. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact